Product Form


RENVORAB SL


COMPOSITION: Each hard gelatin capsule contains enteric coated Rabeprazole Sodium 20 mg & Levosulpiride SR 75 mg
FORMULATION: CAPSULES
STATUS: PRESCRIPTION ONLY DRUG
DESCRIPTION: Renvorab-SL Capsules contains Rabeprazole, a PPI that inhibits acid & Levosulpiride, an anti-psychotic & Prokinetic drug that increases the movement in GI tract. It is indicated in the treatment of gastroesophageal reflux disease (GERD) in Patients who do not respond to monotherapy with PPI’s. It is also indicated in Zollinger-Ellison syndrome, gastric and duodenal ulcers.
SIDE EFFECTS: Common side effects are headache, nausea, vomiting, gas, joint pain, diarrhea and dizziness
DOSAGE/DIRECTIONS FOR USE: As Prescribed by Physician